Page 2 - Shannon Westin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shannon westin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shannon Westin Today - Breaking & Trending Today

Double Good, Triple Therapy Better in Endometrial Cancer?

The fast pace of progress in endometrial cancer has taken a step forward with two trials underlining the benefit of immunotherapy plus chemo, while suggesting adding a PARP inhibitor could further boost outcomes. ....

United States , Friuli Venezia Giulia , Sri Lanka , Genentech Roche , Nuvation Bio , Shannon Westin , Merck Serono , University Of Valencia , Boehringer Ingelheim , National University Cancer Institute , Jazz Pharmaceuticals , European Society For Medical Oncology , Md Anderson Cancer Center , University Of Milan , Mario Negri Institute For Pharmacological Research , European Society , Medical Oncology , Annual Meeting , Clinical Oncology , Nicoletta Colombo , European Institute , Oncology Istituto , Carattere Scientifico , Cancer Center , Mario Negri Institute , Clovis Oncology ,

Dr Westin on Durvalumab and Chemotherapy With or Without Maintenance Olaparib in Endometrial Cancer

Shannon N. Westin, MD, MPH, FACOG, discusses key data on the use of durvalumab plus chemotherapy followed by durvalumab and olaparib maintenance in the phase 3 DUO-E trial of patients with newly diagnosed advanced or recurrent endometrial cancer. ....

United States , Shannon Westin , Early Drug Development , University Of Texas Md Anderson Cancer Center , Division Of Surgery , Department Of Gynecologic Oncology , Gynecologic Oncology , Reproductive Medicine , Cancer Center , The University Of Texas Md Anderson Cancer Center , Onclive Tv , Phase 3 Duoe Trial Nct04269200 , Durvalumab And Olaparib Lynparza , Advanced Or Recurrent Endometrial Cancer ,

AstraZeneca announces positive data for endometrial cancer treatment

AstraZeneca has announced positive high-level data from its DUO-E phase 3 trial for patients with endometrial cancer. ....

Shannon Westin , Susan Galbraith , University Of Texas , Gynecologic Oncology , Reproductive Medicine , Bio Developments , Phase 3 ,

AstraZeneca's Lynparza Results in Favorable Surgical Outcomes for Ovarian Cancer

Clinical trial findings show that olaparib, given in the neoadjuvant setting, was feasible with 100% of participants able to receive the planned 2 cycles. ....

Shannon Westin , Society Of Gynecologic Oncology , Neoadjuvant Olaparib Window , Gynecologic Oncology ,

These Tiny Beads May Offer Big Hope to Ovarian Cancer Patients – Texas Monthly

A Rice University bioengineer’s mini “drug factories” could save thousands of lives. ....

United States , Rice University , Robertp Edwards , Jim Allison , Amir Jazaeri , Omid Veiseh , Shannon Westin , David Miller , Julie Coppage , Division Of Gynecologic Oncology , Ut Southwestern Medical Center , University Of Pittsburgh , Md Anderson Cancer Center , Md Anderson Gynecologic Cancer Immunotherapy Program , Cancer Center , Iran Iraq War , Gynecologic Oncology , Medical Center , American Eskimo ,